2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 8.114 | 24.787 | 9.957 | 25.464 | 29.092 | 11.721 | 13.855 | 10.846 | 4.575 | 4.879 |
Total Income - EUR | 8.115 | 25.218 | 12.817 | 26.645 | 30.253 | 12.856 | 14.968 | 11.935 | 5.667 | 5.580 |
Total Expenses - EUR | 6.428 | 22.212 | 12.757 | 15.251 | 20.543 | 12.399 | 16.846 | 17.339 | 18.589 | 10.752 |
Gross Profit/Loss - EUR | 1.688 | 3.006 | 61 | 11.393 | 9.710 | 457 | -1.877 | -5.404 | -12.922 | -5.172 |
Net Profit/Loss - EUR | 1.540 | 2.587 | 50 | 9.570 | 9.419 | 340 | -2.015 | -5.513 | -12.967 | -5.221 |
Employees | 0 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 1 |
Check the financial reports for the company - Biorara Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 4.984 | 10.893 | 10.162 | 8.473 | 17.475 | 12.622 | 7.953 | 3.445 | 826 | 0 |
Current Assets | 10.914 | 4.661 | 7.754 | 15.378 | 19.115 | 17.018 | 20.492 | 15.204 | 4.387 | 2.658 |
Inventories | 522 | 526 | 1.128 | 1.262 | 1.655 | 1.623 | 1.592 | 1.557 | 0 | 0 |
Receivables | 9.611 | 0 | 2.476 | 4.960 | 15.805 | 14.800 | 13.990 | 8.927 | 2.358 | 2.325 |
Cash | 781 | 4.135 | 4.150 | 7.405 | 1.655 | 595 | 4.909 | 4.720 | 2.029 | 333 |
Shareholders Funds | 1.543 | 4.245 | 4.251 | 13.750 | 21.928 | 21.843 | 19.414 | 13.471 | 546 | -4.677 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 4.643 | 3.967 | 13.664 | 3.448 | 9.289 | 3.661 | 6.087 | 3.388 | 3.963 | 7.335 |
Income in Advance | 9.611 | 9.261 | 7.967 | 6.653 | 5.374 | 4.135 | 2.943 | 1.790 | 703 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7022 - 7022" | |||||||||
CAEN Financial Year |
7022
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Biorara Srl